probenecid has been researched along with methotrexate in 98 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 33 (33.67) | 18.7374 |
1990's | 14 (14.29) | 18.2507 |
2000's | 30 (30.61) | 29.6817 |
2010's | 21 (21.43) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Graves, P; Kuze, K; Leahy, A; Stuhlmann, H; Wilson, P; You, G | 1 |
Chan, BS; Lu, R; Schuster, VL | 1 |
Hashimoto, Y; Ibaramoto, K; Inui, KI; Masuda, S; Saito, H; Takeuchi, A | 1 |
Cha, SH; Endou, H; Kanai, Y; Kojima, R; Kusuhara, H; Sekine, T; Sugiyama, Y; Tsuda, M; Utsunomiya-Tate, N | 1 |
Bakos, E; Borst, P; Evers, R; Sarkadi, B; Sinkó, E; Váradi, A | 1 |
Topliss, JG; Yoshida, F | 1 |
Cha, SH; Endou, H; Fukushima , JI; Goya, T; Kanai, Y; Kobayashi, Y; Sekine, T | 1 |
Belinsky, MG; Chen, ZS; Kruh, GD; Rea, PA; Zeng, H | 1 |
Bindels, RJM; Peters, JGP; Russel, FGM; Smeets, PHE; van Aubel, RAMH | 1 |
Cha, SH; Endou, H; Hosoyamada, M; Khamdang, S; Kimura, H; Narikawa, S; Sekine, T; Takeda, M | 1 |
Berryman, E; Chen, C; Franco, J; Hanson, E; Liu, X; Scott, D; Volberg, M | 1 |
Hummel-Eisenbeiss, J; Jedlitschky, G; Keppler, D; Nies, AT; Rius, M | 1 |
Hori, S; Kikkawa, T; Mori, S; Ohtsuki, S; Otagiri, M; Takanaga, H; Terasaki, T | 1 |
Belinsky, MG; Chen, ZS; Guo, Y; Kotova, E; Kruh, GD | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Eraly, SA; Kaler, G; Khandelwal, A; Nagle, M; Nigam, SK; Swaan, PW; Truong, DM | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Masseno, V; Muriithi, S; Nzila, A | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Benet, LZ; Brouwer, KL; Chu, X; Dahlin, A; Evers, R; Fischer, V; Giacomini, KM; Hillgren, KM; Hoffmaster, KA; Huang, SM; Ishikawa, T; Keppler, D; Kim, RB; Lee, CA; Niemi, M; Polli, JW; Sugiyama, Y; Swaan, PW; Tweedie, DJ; Ware, JA; Wright, SH; Yee, SW; Zamek-Gliszczynski, MJ; Zhang, L | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Barber, J; Dawson, S; Kenna, JG; Paul, N; Stahl, S | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Fent, K; Popovic, M; Smital, T; Zaja, R | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Huang, KC; Liu, YK; Wenczak, BA | 1 |
Biddlecome, SM; Bourke, RS; Kimelberg, HK | 1 |
Howell, SB; Olshen, RA; Rice, JA | 1 |
Blaschke, T; Fusner, JE; Glaubiger, DL; Ramu, A | 1 |
Aherne, GW; Marks, V; Mould, G; Piall, E; White, WF | 1 |
Aherne, GW; Marks, V; Mould, GP; Piall, E; White, WF | 1 |
Blaschke, TF; Eldridge, N; Glaubiger, D; Ramu, A; Ramu, NP | 1 |
Domer, FR; Kaiser, LR | 1 |
Kates, RE; Sorby, DL; Tozer, TN | 1 |
Kates, RE; Tozer, TN | 1 |
Spector, R | 1 |
Bourke, RS; Bremer, A; Chheda, G; Tower, DB; Watanabe, O | 1 |
Henderson, GB | 1 |
Henderson, GB; Strauss, BP | 1 |
O'Leary, DF; Sirotnak, FM | 1 |
Basin, KS; Beardmore, TD; Escalante, A | 1 |
Henderson, GB; Tsuji, JM | 1 |
Weinblatt, ME | 1 |
Besseghir, K; Mosig, D; Roch-Ramel, F | 1 |
Furst, DE | 1 |
Brasch, H; Iven, H | 2 |
Gale, GR; Hynes, JB; Smith, AB | 1 |
Lilly, MB; Omura, GA | 1 |
Christensen, ML; Evans, WE | 1 |
Henderson, GB; Kumar, HP; Tsuji, JM | 1 |
Gewirtz, DA; Holt, SA | 1 |
Henderson, GB; Zevely, EM | 1 |
Fry, DW; Goldman, ID; Yalowich, JC | 1 |
Brooks, PM; Buchanan, WW; Kassam, Y; Kean, WF | 1 |
Bleyer, WA; Gangji, D; Glaubiger, DL; Poplack, DG; Ross, WE | 1 |
Paxton, JW | 1 |
Gewirtz, DA; Plotkin, JH; Randolph, JK | 1 |
Nierenberg, DW | 1 |
Borthwick-Clarke, C; Gravett, PJ | 1 |
Hancock, CH; Moccio, DM; Sirotnak, FM; Young, CW | 1 |
Bleyer, WA; Bode, U; Glaubiger, DL; Magrath, IT; Poplack, DG | 1 |
Moccio, DM; Sirotnak, FM; Young, CW | 1 |
Brigle, KE; Goldman, ID; Sierra, EE; Spinella, MJ | 2 |
Henderson, GB; Hughes, TR | 1 |
McCloud, E; Mohammadkhani, R; Said, HM | 1 |
Hashimoto, Y; Inui, K; Okuda, M; Takami, K; Uwai, Y | 1 |
Bacher, JD; Balis, FM; Blaney, SM; McCully, CL; Murphy, RF; Poplack, DG | 1 |
Inui, K; Saito, H; Uwai, Y | 1 |
Kato, Y; Komatsu, K; Sugiyama, Y; Ueda, K | 1 |
Adamson, PC; Balis, FM; McCully, C; Salzer, W; Widemann, B | 1 |
Fujisawa, R; Hanada, K; Kataoka, R; Nakamura, S; Ogata, H | 1 |
Horne, DW; Reed, KA | 1 |
Cai, S; Horne, DW | 1 |
Lim, BG; Ng, KH; Wong, KP | 1 |
Chen, V; Dantzig, AH; Perry, WI; Pratt, S; Starling, JJ | 1 |
Hamada, N; Nagai, J; Ogawa, K; Takano, M; Yumoto, R | 1 |
Itoh, T; Narawa, T; Tsuda, Y | 1 |
Announ, N; Guerne, PA | 1 |
Böhlke, M; Henry, K; Kim, J; Maher, TJ; Sani, SN; Stricker-Krongrad, A | 1 |
Chakilam, AR; Jayaraj, A; Taft, DR; Tamhane, M; Thakkar, V | 1 |
Mori, N; Murakami, T; Yokooji, T | 1 |
Beveridge, S; Biagini, GA; Bray, PG; Johnson, D; Krishna, S; Nzila, A; O'Neill, PM; Ochong, E; Salcedo-Sora, JE; Stocks, PA; Ward, SA | 1 |
Agarwal, S; Elmquist, WF; Li, L | 1 |
Danhof, M; de Lange, EC; Hartman, R; van den Berg, DJ; Westerhout, J | 1 |
Flores, K; Manautou, JE; Renfro, JL | 1 |
Hamada, Y; Ikemura, K; Iwamoto, T; Okuda, M | 1 |
Gynther, M; Huttunen, J; Huttunen, KM | 1 |
6 review(s) available for probenecid and methotrexate
Article | Year |
---|---|
Membrane transporters in drug development.
Topics: Animals; Computer Simulation; Decision Trees; Drug Approval; Drug Discovery; Drug Evaluation, Preclinical; Drug Interactions; Humans; Membrane Transport Proteins; Mice; Mice, Knockout; Prescription Drugs | 2010 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Clinically important interactions of nonsteroidal antiinflammatory drugs with other medications.
Topics: Adrenal Cortex Hormones; Adrenergic beta-Antagonists; Antacids; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Diuretics; Drug Interactions; Humans; Hypoglycemic Agents; Lithium; Methotrexate; Phenytoin; Probenecid; Salicylates; Triamterene | 1988 |
Drug interactions with methotrexate.
Topics: Absorption; Anti-Bacterial Agents; Arthritis, Rheumatoid; Aspirin; Biological Transport; Cell Membrane; Cisplatin; Dose-Response Relationship, Drug; Drug Interactions; Folic Acid; Humans; Kidney Tubules; Methotrexate; Probenecid; Protein Binding; Salicylates; Serum Albumin; Sulfamethoxazole; Sulfonamides; Tissue Distribution | 1985 |
Problems of antiarthritic therapy in the elderly.
Topics: Adrenal Cortex Hormones; Age Factors; Aged; Allopurinol; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Arthritis, Rheumatoid; Chloroquine; Female; Gold; Gout; Humans; Male; Methotrexate; Middle Aged; Osteoarthritis; Penicillamine; Probenecid | 1984 |
Treating difficult crystal pyrophosphate dihydrate deposition disease.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Calcium Pyrophosphate; Chondrocalcinosis; Colchicine; Glucocorticoids; Humans; Magnesium Compounds; Methotrexate; Probenecid; Uricosuric Agents | 2008 |
1 trial(s) available for probenecid and methotrexate
Article | Year |
---|---|
Clinical pharmacology of oral intermediate-dose methotrexate with or without probenecid.
Topics: Administration, Oral; Clinical Trials as Topic; Drug Administration Schedule; Humans; Methotrexate; Neoplasms; Probenecid | 1985 |
91 other study(ies) available for probenecid and methotrexate
Article | Year |
---|---|
Heterologous expression and functional characterization of a mouse renal organic anion transporter in mammalian cells.
Topics: Animals; Anion Transport Proteins; Biological Transport; Carrier Proteins; COS Cells; Glycosylation; Histidine; In Situ Hybridization; Kidney; Kinetics; Mice; p-Aminohippuric Acid; Probenecid; Protein Processing, Post-Translational; Renal Agents; Substrate Specificity; Tunicamycin | 1999 |
Cloning of the human kidney PAH transporter: narrow substrate specificity and regulation by protein kinase C.
Topics: Amino Acid Sequence; Animals; Carrier Proteins; Chromosome Mapping; Chromosomes, Human, Pair 11; Cloning, Molecular; DNA, Complementary; HeLa Cells; Humans; Kidney; Molecular Sequence Data; p-Aminohippuric Acid; Protein Kinase C; Rats; Substrate Specificity; Tissue Distribution | 1999 |
Cloning and functional characterization of a new multispecific organic anion transporter, OAT-K2, in rat kidney.
Topics: Amino Acid Sequence; Animals; Base Sequence; Carrier Proteins; Cloning, Molecular; DNA, Complementary; Kidney; Male; Membrane Proteins; Molecular Sequence Data; Multidrug Resistance-Associated Proteins; Oocytes; Organic Anion Transporters; Rats; Rats, Wistar; RNA, Messenger; Sequence Homology, Amino Acid; Sequence Homology, Nucleic Acid; Tissue Distribution; Transfection; Xenopus laevis | 1999 |
Molecular cloning and characterization of a new multispecific organic anion transporter from rat brain.
Topics: Amino Acid Sequence; Animals; Brain; Carrier Proteins; Cloning, Molecular; DNA, Complementary; Estrone; Molecular Sequence Data; Ochratoxins; Organic Anion Transporters, Sodium-Independent; p-Aminohippuric Acid; Rats; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sequence Homology, Amino Acid; Xenopus laevis | 1999 |
Interactions of the human multidrug resistance proteins MRP1 and MRP2 with organic anions.
Topics: Adenosine Triphosphatases; Animals; Anions; Biological Transport; Cell Membrane; Cells, Cultured; DNA-Binding Proteins; Drug Resistance, Multiple; Glutathione; Humans; Insecta; Membrane Transport Proteins; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; MutS Homolog 3 Protein | 2000 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney.
Topics: Amino Acid Sequence; Animals; Carrier Proteins; Chromosome Mapping; Chromosomes, Human, Pair 11; Cloning, Molecular; Gene Library; Humans; Kidney Tubules, Proximal; Molecular Sequence Data; Oocytes; Organic Anion Transporters, Sodium-Independent; Sequence Homology, Amino Acid; Tissue Distribution; Transfection; Xenopus laevis | 2001 |
Transport of methotrexate (MTX) and folates by multidrug resistance protein (MRP) 3 and MRP1: effect of polyglutamylation on MTX transport.
Topics: 3T3 Cells; Animals; ATP-Binding Cassette Transporters; Biological Transport; Drug Resistance, Multiple; Folic Acid; Humans; Leucovorin; Methotrexate; Mice; Multidrug Resistance-Associated Proteins; Osmolar Concentration; Polyglutamic Acid; Tritium | 2001 |
The MRP4/ABCC4 gene encodes a novel apical organic anion transporter in human kidney proximal tubules: putative efflux pump for urinary cAMP and cGMP.
Topics: Adenosine Triphosphate; Animals; Cell Line; Cell Membrane; Cyclic AMP; Cyclic GMP; Estradiol; Humans; Immunohistochemistry; Insecta; Kidney Tubules, Proximal; Methotrexate; Multidrug Resistance-Associated Proteins; Organic Anion Transporters; Rats; Tissue Distribution | 2002 |
Characterization of methotrexate transport and its drug interactions with human organic anion transporters.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biological Transport; Cells, Cultured; Humans; Indomethacin; Kinetics; Liver-Specific Organic Anion Transporter 1; Methotrexate; Mice; Mice, Transgenic; Nerve Tissue Proteins; Organic Anion Transporters, Sodium-Independent; Phenylbutazone; Potassium Channels; Potassium Channels, Tandem Pore Domain; Probenecid | 2002 |
Impact of Mrp2 on the biliary excretion and intestinal absorption of furosemide, probenecid, and methotrexate using Eisai hyperbilirubinemic rats.
Topics: Animals; ATP-Binding Cassette Transporters; Biliary Tract; Carrier Proteins; Furosemide; Hyperbilirubinemia; Intestinal Absorption; Male; Methotrexate; Probenecid; Rats; Rats, Mutant Strains; Rats, Sprague-Dawley | 2003 |
Cotransport of reduced glutathione with bile salts by MRP4 (ABCC4) localized to the basolateral hepatocyte membrane.
Topics: Adenosine Triphosphate; Amino Acid Sequence; Animals; Antibodies; Carcinoma, Hepatocellular; Cell Polarity; Cholagogues and Choleretics; Cricetinae; Fibroblasts; Gene Expression; Glutathione; Hepatocytes; Humans; Liver Neoplasms; Male; Mice; Molecular Sequence Data; Multidrug Resistance-Associated Proteins; Rats; Taurocholic Acid; Transfection; Transport Vesicles; Tritium | 2003 |
Mouse reduced in osteosclerosis transporter functions as an organic anion transporter 3 and is localized at abluminal membrane of blood-brain barrier.
Topics: Animals; Biological Transport; Blood-Brain Barrier; Capillaries; Disease Models, Animal; Estrone; Male; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Osteosclerosis; Penicillin G; RNA, Messenger | 2004 |
Transport of bile acids, sulfated steroids, estradiol 17-beta-D-glucuronide, and leukotriene C4 by human multidrug resistance protein 8 (ABCC11).
Topics: Animals; ATP-Binding Cassette Transporters; Bile Acids and Salts; Dose-Response Relationship, Drug; Estradiol; Humans; Leukotriene C4; LLC-PK1 Cells; Protein Transport; Swine | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Structural variation governs substrate specificity for organic anion transporter (OAT) homologs. Potential remote sensing by OAT family members.
Topics: Binding Sites; Hydrophobic and Hydrophilic Interactions; Kinetics; Molecular Structure; Organic Anion Transport Protein 1; Organic Anion Transporters; Static Electricity; Substrate Specificity | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
In vitro chemosensitization of Plasmodium falciparum to antimalarials by verapamil and probenecid.
Topics: Adjuvants, Pharmaceutic; Animals; Antimalarials; Parasitic Sensitivity Tests; Plasmodium falciparum; Probenecid; Verapamil | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Cholestasis; Drug-Related Side Effects and Adverse Reactions; Humans; Insecta; Rats; Risk Factors | 2012 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Molecular characterization of zebrafish Oatp1d1 (Slco1d1), a novel organic anion-transporting polypeptide.
Topics: Animals; Evolution, Molecular; Glycosylation; Gonadal Steroid Hormones; HEK293 Cells; Humans; Ion Transport; Organic Anion Transporters; Protein Multimerization; Zebrafish; Zebrafish Proteins | 2013 |
Renal tubular transport of methotrexate in the rhesus monkey and dog.
Topics: Animals; Biological Transport, Active; Dogs; Female; Folic Acid; Haplorhini; In Vitro Techniques; Kidney Cortex; Kidney Tubules; Macaca mulatta; Methotrexate; Probenecid; Protein Binding; Species Specificity | 1979 |
Distribution and degradation of [3H]methotrexate after intravenous and cerebral intraventricular injection in primates.
Topics: Animals; Bone Marrow; Brain; Cats; Female; Haplorhini; Infusions, Parenteral; Injections, Intravenous; Injections, Intraventricular; Kidney; Liver; Macaca fascicularis; Macaca mulatta; Male; Methotrexate; Probenecid; Spleen; Time Factors | 1977 |
Effect of probenecid on cerebrospinal fluid methotrexate kinetics.
Topics: Adult; Child, Preschool; Female; Humans; Kinetics; Methotrexate; Middle Aged; Neoplasms; Probenecid | 1979 |
Probenecid inhibition of methotrexate-cerebrospinal fluid pharmacokinetics in dogs.
Topics: Animals; Cisterna Magna; Dogs; Drug Interactions; Half-Life; Injections; Injections, Spinal; Kinetics; Methotrexate; Probenecid | 1978 |
Prolongation and enhancement of serum methotrexate concentrations by probenecid.
Topics: Adult; Aged; Drug Interactions; Female; Humans; Infusions, Parenteral; Injections, Intravenous; Kinetics; Male; Methotrexate; Middle Aged; Probenecid | 1978 |
The interaction between methotrexate and probenecid in man [proceedings].
Topics: Drug Interactions; Humans; Methotrexate; Probenecid | 1978 |
Probenecid inhibition of methotrexate excretion from cerebrospinal fluid in dogs.
Topics: Animals; Dogs; Drug Interactions; Kinetics; Methotrexate; Probenecid | 1978 |
Effects of probenecid on methotrexate exchange between the blood and the cerebrospinal fluid.
Topics: Animals; Female; Injections, Intravenous; Male; Methotrexate; Perfusion; Probenecid; Rabbits; Time Factors | 1977 |
Increased methotrexate toxicity due to concurrent probenecid administration.
Topics: Animals; Bile; Diarrhea; Drug Synergism; Male; Methotrexate; Probenecid; Rats; Time Factors | 1976 |
Biliary secretion of methotrexate in rats and its inhibition by probenecid.
Topics: Animals; Bile; Kinetics; Male; Metabolic Clearance Rate; Methotrexate; Probenecid; Rats | 1976 |
Inhibition of methotrexate transport from cerebrospinal fluid by probenecid.
Topics: Animals; Antineoplastic Agents; Choroid Plexus; In Vitro Techniques; Methotrexate; Probenecid; Rabbits | 1976 |
Inhibition of renal tubular transport of methotrexate by probenecid.
Topics: Aminohippuric Acids; Animals; Biological Transport; Blood Proteins; Carbon Radioisotopes; Depression, Chemical; Dose-Response Relationship, Drug; Glomerular Filtration Rate; Injections, Intravenous; Inulin; Kidney Glomerulus; Kidney Tubules; Macaca; Methotrexate; Probenecid; Protein Binding; Tritium | 1975 |
Separation and inhibitor specificity of a second unidirectional efflux route for methotrexate in L1210 cells.
Topics: Adenosine Triphosphate; Animals; Biological Transport; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Leukemia L1210; Methotrexate; Mice; Probenecid; Prostaglandins A; Quinidine; Reserpine; Sulfobromophthalein; Tumor Cells, Cultured; Verapamil; Vincristine | 1992 |
Evidence for cAMP and cholate extrusion in C6 rat glioma cells by a common anion efflux pump.
Topics: Animals; Antimycin A; Biological Transport, Active; Cholic Acids; Cyclic AMP; Glioma; Isoproterenol; Methotrexate; Probenecid; Prostaglandins A; Rats; Sulfobromophthalein; Tumor Cells, Cultured; Verapamil | 1991 |
The issues of transport multiplicity and energetics pertaining to methotrexate efflux in L1210 cells addressed by an analysis of cis and trans effects of inhibitors.
Topics: Adenosine Triphosphate; Animals; Biological Transport; Energy Metabolism; Leukemia L1210; Methotrexate; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Probenecid; Sulfobromophthalein; Verapamil | 1991 |
Severe pancytopenia in a patient taking low dose methotrexate and probenecid.
Topics: Aged; Arthritis, Rheumatoid; Blood Cell Count; Dose-Response Relationship, Drug; Drug Interactions; Female; Humans; Methotrexate; Pancytopenia; Probenecid | 1991 |
Identification of cholate as a shared substrate for the unidirectional efflux systems for methotrexate in L1210 mouse cells.
Topics: Animals; Biological Transport; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cholic Acids; Cytochalasin B; Folic Acid; Glucose; Leukemia L1210; Methotrexate; Mice; Probenecid; Substrate Specificity; Sulfobromophthalein; Temperature; Tumor Cells, Cultured; Uric Acid; Vincristine | 1990 |
Drug interactions with non steroidal anti-inflammatory drugs (NSAIDs).
Topics: Administration, Oral; Aged; Antacids; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Antihypertensive Agents; Drug Interactions; Histamine H2 Antagonists; Humans; Hypoglycemic Agents; Lithium; Methotrexate; Phenytoin; Probenecid | 1989 |
Transport of methotrexate by the in vitro isolated rabbit proximal tubule.
Topics: Absorption; Animals; Biological Transport; Female; Folic Acid; In Vitro Techniques; Kidney Tubules, Proximal; Male; Methotrexate; Perfusion; Probenecid; Rabbits | 1989 |
The effects of antibiotics and uricosuric drugs on the renal elimination of methotrexate and 7-hydroxymethotrexate in rabbits.
Topics: Animals; Anti-Bacterial Agents; Benzbromarone; Ceftriaxone; Furosemide; Kidney; Metabolic Clearance Rate; Methotrexate; Piperacillin; Probenecid; Rabbits; Sulfamethoxazole; Sulfinpyrazone; Uricosuric Agents | 1988 |
Influence of the antibiotics piperacillin, doxycycline, and tobramycin on the pharmacokinetics of methotrexate in rabbits.
Topics: Animals; Anti-Bacterial Agents; Doxycycline; Drug Interactions; Kinetics; Male; Methotrexate; Piperacillin; Probenecid; Rabbits; Tobramycin | 1986 |
Effects of 5,8-dideazaisopteroylglutamate (IAHQ) on L1210 leukemia in mice when given alone and in combination with methotrexate, probenecid, or verapamil.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Folic Acid Antagonists; Leukemia L1210; Male; Methotrexate; Mice; Mice, Inbred DBA; Probenecid; Quinazolines; Time Factors; Verapamil | 1986 |
Characterization of the individual transport routes that mediate the influx and efflux of methotrexate in CCRF-CEM human lymphoblastic cells.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Carbon Radioisotopes; Carrier Proteins; Cells, Cultured; Glucose; Humans; Intracellular Signaling Peptides and Proteins; Kinetics; Leukemia; Leukemia L1210; Lymphocytes; Methotrexate; Mice; Neoplasm Proteins; Oligomycins; Probenecid; Sulfobromophthalein; Tetrahydrofolates; Tritium | 1986 |
Protein binding as a component of drug interaction in cellular pharmacokinetic studies. Effects of probenecid on transport and accumulation of methotrexate in Ehrlich ascites tumor cells in vitro.
Topics: Animals; Biological Transport; Blood Proteins; Carcinoma, Ehrlich Tumor; Dose-Response Relationship, Drug; Drug Interactions; In Vitro Techniques; Male; Methotrexate; Mice; Mice, Inbred Strains; Probenecid; Protein Binding; Serum Albumin | 1985 |
Inhibitory effects of probenecid on the individual transport routes which mediate the influx and efflux of methotrexate in L1210 cells.
Topics: Animals; Biological Transport; Cells, Cultured; Energy Metabolism; Leukemia L1210; Methotrexate; Mice; Probenecid; Sulfates | 1985 |
Augmentation of the intracellular levels of polyglutamyl derivatives of methotrexate by vincristine and probenecid in Ehrlich ascites tumor cells.
Topics: Animals; Carcinoma, Ehrlich Tumor; In Vitro Techniques; Male; Methotrexate; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Peptides; Polyglutamic Acid; Probenecid; Vincristine | 1982 |
Probenecid inhibition of methotrexate cytotoxicity in mouse L1210 leukemia cells.
Topics: Animals; Cell Survival; Colony-Forming Units Assay; Dose-Response Relationship, Drug; Drug Interactions; Interphase; Leukemia L1210; Methotrexate; Mice; Probenecid | 1984 |
Interaction of probenecid with the protein binding of methotrexate.
Topics: Drug Interactions; Half-Life; Humans; Methotrexate; Probenecid; Protein Binding; Serum Albumin; Ultrafiltration | 1984 |
Interaction of probenecid with methotrexate transport and release in the isolated rat hepatocyte in suspension.
Topics: Animals; Biological Transport; In Vitro Techniques; Kinetics; Liver; Male; Methotrexate; Probenecid; Protein Binding; Rats; Rats, Inbred Strains; Tetrahydrofolate Dehydrogenase; Tritium | 1984 |
Competitive inhibition of methotrexate accumulation in rabbit kidney slices by nonsteroidal anti-inflammatory drugs.
Topics: 2,4-Dinitrophenol; Animals; Anti-Inflammatory Agents; Aspirin; Binding, Competitive; Dinitrophenols; Kidney Cortex; Kinetics; Methotrexate; Nitrogen; p-Aminohippuric Acid; Probenecid; Rabbits | 1983 |
The use of granulocyte transfusion: a case report.
Topics: Adult; Blood Transfusion; Choriocarcinoma; Female; Granulocytes; Humans; Methotrexate; Military Medicine; Platelet Transfusion; Pregnancy; Probenecid; Uterine Neoplasms | 1980 |
Improved methotrexate therapy of murine tumors obtained by probenecid-mediated pharmacological modulation at the level of membrane transport.
Topics: Animals; Biological Transport, Active; Bone Marrow; Female; Kidney; Kinetics; Leukemia L1210; Liver; Methotrexate; Mice; Mice, Inbred Strains; Probenecid; Sarcoma 180 | 1981 |
Active transport of methotrexate from cerebrospinal fluid in humans.
Topics: Acetazolamide; Adolescent; Biological Transport, Active; Cerebral Ventricles; Child; Half-Life; Humans; Infusions, Parenteral; Injections, Intraventricular; Kinetics; Methotrexate; Probenecid | 1980 |
Increased accumulation of methotrexate by murine tumor cells in vitro in the presence of probenecid which is mediated by a preferential inhibition of efflux.
Topics: Animals; Biological Transport; Carcinoma, Ehrlich Tumor; Leukemia L1210; Methotrexate; Mice; Neoplasms, Experimental; Probenecid; Sarcoma, Experimental | 1981 |
Comparison of transport properties of the reduced folate carrier and folate receptor in murine L1210 leukemia cells.
Topics: Animals; Biological Transport; Carrier Proteins; Folate Receptors, GPI-Anchored; Hydrogen-Ion Concentration; Kinetics; Leukemia L1210; Membrane Proteins; Membrane Transport Proteins; Methotrexate; Mice; Probenecid; Receptors, Cell Surface; Reduced Folate Carrier Protein; Sulfobromophthalein; Tumor Cells, Cultured | 1995 |
Distinguishing between folate receptor-alpha-mediated transport and reduced folate carrier-mediated transport in L1210 leukemia cells.
Topics: Alkenes; Animals; Biological Transport; Carrier Proteins; Energy Metabolism; Folate Receptors, GPI-Anchored; Folic Acid; Hydrogen-Ion Concentration; Ions; Leukemia L1210; Membrane Proteins; Membrane Transport Proteins; Methotrexate; Mice; Polyenes; Probenecid; Pyrones; Receptors, Cell Surface; Reduced Folate Carrier Protein; Sulfobromophthalein; Temperature; Transfection; Tumor Cells, Cultured | 1995 |
Altered expression of unidirectional extrusion routes for methotrexate and cholate in an efflux variant of L1210 cells.
Topics: Animals; Cell Division; Cholic Acids; Drug Interactions; Drug Tolerance; Exocytosis; Leukemia L1210; Methotrexate; Mice; Probenecid; Sulfobromophthalein; Tumor Cells, Cultured | 1993 |
Mechanism of transport of riboflavin in rabbit intestinal brush border membrane vesicles.
Topics: 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid; 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Animals; Biological Transport; Folic Acid; Furosemide; Ileum; Intestinal Mucosa; Jejunum; Kinetics; Membrane Potentials; Methotrexate; Microvilli; Organ Specificity; Osmolar Concentration; Potassium; Probenecid; Rabbits; Riboflavin; Valinomycin | 1993 |
Functional characterization of the rat multispecific organic anion transporter OAT1 mediating basolateral uptake of anionic drugs in the kidney.
Topics: Animals; Anion Transport Proteins; Anions; Biological Transport; Carrier Proteins; Cell Membrane; Dicarboxylic Acids; Diterpenes; DNA Primers; DNA, Complementary; Female; Folic Acid; Glutarates; Kidney; Kinetics; Methotrexate; Oocytes; p-Aminohippuric Acid; Phorbol Esters; Probenecid; Rats; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Staurosporine; Terpenes; Tetradecanoylphorbol Acetate; Xenopus laevis | 1998 |
Methotrexate distribution within the subarachnoid space after intraventricular and intravenous administration.
Topics: Animals; Antimetabolites, Antineoplastic; Brain; Cerebral Ventricles; Dose-Response Relationship, Drug; Infusions, Intravenous; Infusions, Parenteral; Injections, Intraventricular; Macaca mulatta; Male; Metabolic Clearance Rate; Methotrexate; Probenecid; Subarachnoid Space; Uricosuric Agents | 2000 |
Interaction between methotrexate and nonsteroidal anti-inflammatory drugs in organic anion transporter.
Topics: Animals; Anion Transport Proteins; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites, Antineoplastic; Carrier Proteins; Kinetics; Methotrexate; Oocytes; Probenecid; Uricosuric Agents; Xenopus laevis | 2000 |
Inhibition of biliary excretion of methotrexate by probenecid in rats: quantitative prediction of interaction from in vitro data.
Topics: Animals; Bile; Biliary Tract; Biological Transport, Active; Cytoplasmic Vesicles; Dose-Response Relationship, Drug; Drug Interactions; Hepatocytes; Liver; Male; Metabolic Clearance Rate; Methotrexate; Models, Biological; Probenecid; Rats; Rats, Sprague-Dawley | 2001 |
Effect of probenecid on ventricular cerebrospinal fluid methotrexate pharmacokinetics after intralumbar administration in nonhuman primates.
Topics: Animals; Antimetabolites, Antineoplastic; Area Under Curve; Cerebral Ventricles; Cerebrospinal Fluid; Drug Administration Routes; Infusions, Intravenous; Injections, Intraventricular; Injections, Spinal; Lumbosacral Region; Macaca mulatta; Methotrexate; Probenecid; Toxicity Tests; Uricosuric Agents | 2001 |
Sex-related differences in the renal disposition of the acidic metabolite of clentiazem in rat.
Topics: Animals; Calcium Channel Blockers; Chromatography, High Pressure Liquid; Diltiazem; Female; Folic Acid Antagonists; Kidney; Male; Methotrexate; Probenecid; Protein Binding; Rats; Rats, Sprague-Dawley; Renal Agents; Sex Characteristics | 2001 |
Transport of methotrexate into LNCaP human prostate cancer cells.
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Biological Transport; Humans; Hydrogen-Ion Concentration; Kinetics; Male; Methotrexate; Phosphates; Probenecid; Prostatic Neoplasms; Sulfates; Tumor Cells, Cultured | 2002 |
Transport of 5-formyltetrahydrofolate into primary cultured rat astrocytes.
Topics: 4-Chloromercuribenzenesulfonate; 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Animals; Arsenates; Astrocytes; Biological Transport; Buffers; Cells, Cultured; Enzyme Inhibitors; Ethanol; Folic Acid; Hydrogen-Ion Concentration; Leucovorin; Methotrexate; Probenecid; Rats; Rats, Sprague-Dawley; Sodium Cyanide; Tetrahydrofolates | 2003 |
Sulfate conjugating and transport functions of MDCK distal tubular cells.
Topics: Animals; Biological Transport; Buthionine Sulfoximine; Carcinoma, Hepatocellular; Cell Line, Tumor; Cyclosporine; Glutathione; Harmine; Humans; Immunosuppressive Agents; Kidney Tubules, Distal; Leukotriene Antagonists; Liver; Membrane Transport Proteins; Methotrexate; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Organic Anion Transport Protein 1; Probenecid; Propionates; Quinolines; Radiation-Protective Agents; Radiation-Sensitizing Agents; Sulfates; Uricosuric Agents | 2003 |
Kinetic validation of the use of carboxydichlorofluorescein as a drug surrogate for MRP5-mediated transport.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Antimetabolites, Antineoplastic; Cyclic Nucleotide Phosphodiesterases, Type 5; Fluoresceins; Fluorescent Dyes; Glutamates; Guanine; HeLa Cells; Humans; Kinetics; Membrane Transport Proteins; Methotrexate; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Pemetrexed; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Probenecid; Propionates; Quinolines; Reproducibility of Results; Staining and Labeling; Transfection | 2006 |
Interaction of valproic acid and carbapenem antibiotics with multidrug resistance-associated proteins in rat erythrocyte membranes.
Topics: Adenosine Triphosphate; Animals; Anti-Bacterial Agents; Carbapenems; Dose-Response Relationship, Drug; Drug Interactions; Erythrocyte Membrane; Glutathione; Indomethacin; Methotrexate; Multidrug Resistance-Associated Proteins; Probenecid; Rats; Transport Vesicles; Valproic Acid | 2006 |
Chiral recognition of amethopterin enantiomers by the reduced folate carrier in Caco-2 cells.
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Algorithms; Caco-2 Cells; Chromatography, Liquid; Folic Acid; Folic Acid Antagonists; Humans; Mass Spectrometry; Methotrexate; Probenecid; Proteins; Reduced Folate Carrier Protein; Stereoisomerism; Uricosuric Agents | 2007 |
The effects of drug transporter inhibitors on the pharmacokinetics and tissue distribution of methotrexate in normal and tumor-bearing mice: a microdialysis study.
Topics: Animals; ATP-Binding Cassette Transporters; Cell Line, Tumor; Cyclosporine; Drug Delivery Systems; Drug Interactions; Female; Humans; Methotrexate; Mice; Mice, Nude; Microdialysis; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Neoplasms; Probenecid; Tissue Distribution; Xenograft Model Antitumor Assays | 2010 |
Comparative renal excretion of VX-702, a novel p38 MAPK inhibitor, and methotrexate in the perfused rat kidney model.
Topics: Algorithms; Animals; Antirheumatic Agents; Cimetidine; Drug Interactions; Enzyme Inhibitors; Glomerular Filtration Rate; Immunologic Factors; Kidney; Kinetics; Male; Methotrexate; Organic Anion Transporters; Organic Cation Transport Proteins; Osmolar Concentration; p38 Mitogen-Activated Protein Kinases; Perfusion; Phenylurea Compounds; Probenecid; Rats; Rats, Sprague-Dawley; Ultrafiltration | 2010 |
Modulated pharmacokinetics and increased small intestinal toxicity of methotrexate in bilirubin-treated rats.
Topics: Alkaline Phosphatase; Animals; Biliary Tract; Bilirubin; Biological Transport; Drug Interactions; Hyperbilirubinemia; Intestinal Absorption; Intestinal Mucosa; Jejunum; Male; Methotrexate; Multidrug Resistance-Associated Proteins; Probenecid; Rats; Rats, Sprague-Dawley | 2011 |
The molecular basis of folate salvage in Plasmodium falciparum: characterization of two folate transporters.
Topics: Biological Transport, Active; Escherichia coli; Folic Acid; Folic Acid Antagonists; Folic Acid Transporters; Humans; Methotrexate; Plasmodium falciparum; Probenecid; Protozoan Proteins; Uricosuric Agents | 2011 |
Brain efflux index to investigate the influence of active efflux on brain distribution of pemetrexed and methotrexate.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Blood-Brain Barrier; Capillary Permeability; Folic Acid Antagonists; Glutamates; Guanine; Half-Life; Male; Methotrexate; Mice; Mice, Inbred C57BL; Mice, Knockout; Microinjections; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Organic Anion Transporters, Sodium-Independent; Pemetrexed; Penicillin G; Probenecid | 2013 |
Prediction of methotrexate CNS distribution in different species - influence of disease conditions.
Topics: Adult; Age Factors; Animals; Antimetabolites, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B; Central Nervous System; Child; Disease; Dogs; Humans; Male; Methotrexate; Microdialysis; Models, Biological; Organic Anion Transporters; Probenecid; Rats, Wistar; Reproducibility of Results; Species Specificity; Systems Biology; Tissue Distribution | 2014 |
Gender-specific expression of ATP-binding cassette (Abc) transporters and cytoprotective genes in mouse choroid plexus.
Topics: Animals; ATP-Binding Cassette Transporters; Blood-Brain Barrier; Choroid Plexus; Female; Gene Expression Regulation; Kidney; Liver; Male; Methotrexate; Mice; Mice, Inbred C57BL; Mice, Knockout; Multidrug Resistance-Associated Proteins; NF-E2-Related Factor 2; Probenecid; Sex Factors | 2017 |
Stereoselective Inhibition of Renal Basolateral Human Organic Anion Transporter 3 by Lansoprazole Enantiomers.
Topics: Drug Interactions; Estrone; HEK293 Cells; Humans; Kidney; Lansoprazole; Methotrexate; Organic Anion Transport Protein 1; Organic Anion Transporters, Sodium-Independent; p-Aminohippuric Acid; Pemetrexed; Probenecid; Proton Pump Inhibitors; Stereoisomerism | 2018 |
Targeted efflux transporter inhibitors - A solution to improve poor cellular accumulation of anti-cancer agents.
Topics: Antineoplastic Agents; Biological Transport; Cell Line; Drug Synergism; Humans; Membrane Transport Proteins; Methotrexate; Probenecid; Prodrugs; Vinblastine | 2018 |